The LP-1 and OCI-MY5 MM cells treated with 5-aza-2′-deoxycytidine (5-azadC) exhibited partial methylation of the KIAA0495 gene, leading to progressive demethylation of the KIAA0495 promoter [128]. The gene discussed is GFOD3P; the disease is Miyoshi myopathy.